About DPT Laboratories
DPT Laboratories is a company based in San Antonio (United States) founded in 1938 was acquired by Mylan in June 2016. DPT Laboratories offers products and services including CDMO Services, Manufacturing Services, and Packaging Services. DPT Laboratories operates in a competitive market with competitors including Crown Laboratories, Famar, Encube Ethicals, Curida and Formulated Solutions, among others.
- Headquarter San Antonio, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dpt Laboratories, Ltd.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DPT Laboratories
DPT Laboratories offers a comprehensive portfolio of products and services, including CDMO Services, Manufacturing Services, and Packaging Services.
Services for drug pre-formulation, formulation, and analytical testing.
cGMP manufacturing of semi-solids, liquids, and aerosols products.
Process development and packaging for pharmaceutical supplies.
People of DPT Laboratories
Unlock access to complete
Funding Insights of DPT Laboratories
Detailed funding history for DPT Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DPT Laboratories
DPT Laboratories has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Mylan and Renaissance Acquisition Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic and specialty pharmaceuticals are manufactured and marketed globally.
|
Locked | Locked | Locked | |
|
Online gaming and gambling platform
|
Locked | Locked | Locked |
Investor details for DPT Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DPT Laboratories
Investment portfolio details for DPT Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DPT Laboratories
Detailed financials for DPT Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dpt Laboratories Comparisons
Peer comparison for DPT Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DPT Laboratories
DPT Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Crown Laboratories, Famar, Encube Ethicals, Curida and Formulated Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
OTC, prescription, skin care, and oral care products are manufactured.
|
|
| Locked | Locked | Locked |
Contract manufacturing and development services provider
|
|
| Locked | Locked | Locked |
Contract development and manufacturing for topical semisolid formulations are provided.
|
|
| Locked | Locked | Locked |
Liquid pharmaceuticals are developed via blow fill seal technology.
|
|
| Locked | Locked | Locked |
Company offering CDMO services for the pharma (Rx and OTC), medical device, personal care and veterinary medicine sectors
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing of semi-solid pharmaceutical drugs
|
Detailed competitors of DPT Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dpt Laboratories
Complete news archive for DPT Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DPT Laboratories
DPT Laboratories was founded in 1938.
DPT Laboratories is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Heather Bresch is the current CEO of DPT Laboratories.
DPT, currently a part of Mylan, is a contract development and manufacturing organization (CDMO) helping pharmaceutical companies in the development of semi-solid and liquid dosage form development. With four cGMP-compliant facilities in San Antonio and Lakewood, N.J, DPT applies a Quality by Design (QbD) methodology to investigate clients product and discover and deliver the solutions from development through commercialization. They specialize in resolving development and manufacturing challenges in sterile (aseptic) and non-sterile semi-solids and liquids. They offer a range of services from drug pre-formulation and formulation, to analytical method development and technology transfers, to production and distribution. In July 2012, DPT was acquired by Renaissance Acquisition Holdings, which in turn sold its topicals-focused specialty and generics business to Mylan in 2016.
DPT Laboratories's top competitors include Encube Ethicals, Famar and Crown Laboratories.
DPT Laboratories offers CDMO Services, Manufacturing Services, and Packaging Services.
DPT Laboratories has 2 investors. Key investors include Mylan, and Renaissance Acquisition Holdings.